comparemela.com

Latest Breaking News On - குமார் பால் - Page 11 : comparemela.com

WHO warns of global surge in COVID cases, deaths as world approaches highest rate of infection

ABC News Turn on desktop notifications for breaking stories about interest? OffOn The WHO said the global infection rate was approaching the highest so far. • 7 min read COVID-19 emergency plagues Brazil, hospitals overflow with patients Field hospitals in Brazil are overflowing and thousands of hospitals are short or out of sedatives. Critics blame the surge on Brazil’s President Jair Bolsonaro for shunning masks and social distancinManish Swarup/AP LONDON The pandemic is reaching deadly new heights across the world, the WHO warned this week, even as the focus in some countries, including the U.S., has shifted toward how quickly to ease restrictions as vaccination figures eke upward.

India wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official

April 13, 20211:05 PM UTC IndiaIndia wants Pfizer, Moderna, Johnson & Johnson to seek licence for COVID-19 vaccines soon - govt official Reuters 1 minute read Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse/File Photo India wants Pfizer, Moderna and Johnson & Johnson to seek licence for their COVID-19 vaccines as soon as possible, a senior government official said on Tuesday, shortly after the government announced it would fast-track emergency approvals. “We hope and we invite the vaccine makers such as Pfizer, Moderna, Johnson & Johnson and others.to be ready to come to India as early as possible,” Vinod Kumar Paul, a senior government health official, told a news conference.

Will Pfizer, Moderna, or J&J vaccines be available in India soon? — Quartz India

April 14, 2021 India is on its way to expand its “vaccine basket.” But is it too little too late? The central government announced a change in its policy yesterday (April 13), under which Covid-19 vaccines that have received emergency approval elsewhere in the world would be fast tracked in India. Approvals by the US Food and Drug Administration, European Medicines Agency, UK’s Medicines and Healthcare products Regulatory Agency, or Japan’s Pharmaceuticals and Medical Devices Agency Japan would grant vaccine makers faster approvals in India. Additionally, those vaccines that are listed in World Health Organization’s “(emergency use listing) may be granted emergency use approval in India,” the health ministry said in a press release.

COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout

COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout Somya Lohia © Somya Lohia COVID-19 Vaccine Update: Many nations pause Johnson & Johnson s vaccine over rare blood clots, India plans rollout The use of Johnson & Johnson s COVID-19 vaccine has been paused in the United States for at least a few days on the recommendation of the US Food and Drug Administration (USFDA) following the development of rare blood clots in few recipients after receiving the shot. The US recommended that states pause giving the J&J vaccine on April 13 while authorities examine six reports of the unusual clots, including a death, out of more than 6.8 million Americans given the one-dose vaccination so far.

India, big vaccine exporter, now seeks imports as Covid cases soar | World

Tuesday, 13 Apr 2021 09:49 PM MYT India has the biggest vaccine manufacturing capacity in the world and had exported tens of millions of doses before its own demand skyrocketed. Reuters pic Subscribe to our Telegram channel for the latest updates on news you need to know. NEW DELHI, April 13 India is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna shots. The move, which will drop the need for companies to do small, local safety trials for their vaccines before seeking emergency approval, follows the world’s biggest surge in cases in the country this month.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.